
Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
September 10, 2026
SALT LAKE CITY, Utah — Canyon Labs, a full-service provider of medical device testing, validation, and regulatory consulting services, today announced expanded Reusable Medical Device Reprocessing Validation services. The offering brings together two distinct capabilities Cleaning Validation and Steam Sterilization Validation, to help manufacturers develop and support reprocessing instructions appropriate to a device’s intended use.
Reusable medical devices do not all follow the same reprocessing pathway. Depending on the device, its clinical use, and the level of patient-contact risk, validated instructions may call for cleaning alone, cleaning followed by manual or thermal disinfection, or cleaning followed by sterilization. Canyon Labs’ expanded offering gives manufacturers a coordinated validation partner while preserving those important distinctions.
“Effective reprocessing starts with understanding the device, how it is used, and the pathway needed to make it safe for the next use,” said Ethan Kitt, Business Development Manager at Canyon Labs. “By adding cleaning and steam sterilization validation as distinct but connected services, we can help customers build practical, science-based instructions that healthcare personnel can perform consistently.”
Two Distinct Services, One Coordinated Program
Cleaning Validation. Canyon Labs works with manufacturers to develop and execute device-specific protocols that challenge proposed manual or automated cleaning instructions under defined worst-case conditions. Programs may include selection and application of representative test soils, simulated-use conditioning, extraction-method qualification, visual inspection, and quantitative residual testing, with acceptance criteria justified for the device and intended use.
Steam Sterilization Validation. For reusable devices whose validated reprocessing instructions include moist-heat sterilization, Canyon Labs supports development and validation of product-specific steam sterilization cycles. Programs may address worst-case device and load configurations, process challenge locations, physical and microbiological performance, drying, and device compatibility across the labeled number of reprocessing cycles.
Built Around the Device and Its Intended Use
The expanded services are designed to support a risk-based validation strategy rather than a one-size-fits-all process. Canyon Labs can help manufacturers translate device design, materials, use conditions, contamination risks, and user needs into validation protocols and clear Instructions for Use (IFUs). Where a device requires disinfection rather than terminal sterilization, the reprocessing pathway and associated claims should be defined and validated accordingly.
By coordinating reprocessing work with Canyon Labs’ microbiology, biocompatibility, analytical chemistry, packaging validation, and regulatory consulting capabilities, manufacturers can address reprocessing earlier in development, evaluate interactions across disciplines, and generate documentation designed to support regulatory submissions and lifecycle changes.
A Partner Throughout the Product Lifecycle
Reprocessing requirements can affect device design, material selection, labeling, verification and validation, and post-market change control. Canyon Labs helps manufacturers plan for those connections from early feasibility through submission support and ongoing product maintenance reducing avoidable rework while keeping patient safety and real-world usability at the center of the program.
About Canyon Labs
Canyon Labs provides integrated testing, validation, and regulatory consulting services for medical device manufacturers. Its capabilities span microbiology, biocompatibility, analytical chemistry, packaging validation, reusable-device reprocessing validation, and regulatory support, helping customers move from development through commercialization with coordinated scientific and compliance expertise.
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India














